The impact of major depressive disorder (MDD) is far reaching, affecting millions of adults in the US. Furthermore, the large majority of these individuals report symptoms related to cognitive dysfunction, yet these symptoms often do not receive focused attention. Recent data has revealed therapeutic options that can aid in addressing these cognitive symptoms and improving patient quality of life. Join us for an expert-lead on-demand video discussing: Insights from an initiative focused on strengthening patient and provider dialogue on cognitive health Strategies for incorporating evidence-based tools to overcome barriers in the routine assessment and management of cognitive dysfunction in MDD The latest clinical evidence on MDD therapies and improving symptoms of cognitive dysfunction Best practices for engaging diverse patients in equitable MDD care
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/addressing-cognitive-dysfunction-mdd-patient-centered-strategies-research
- Start Date: 2024-12-30 06:00:00
- End Date: 2024-12-30 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Takeda Pharmaceuticals (Any division) - Amount: 125000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all